BGU in tie-up with Invitrogen Corp.

Ben-Gurion University of the Negev and Invitrogen Corp, a California-based life-science technology company, signed an agreement to jointly produce products for the biotechnology market, the university said Sunday.

By SETH FREEDMAN
May 29, 2006 07:04

Ben-Gurion University of the Negev and Invitrogen Corp, a California-based life-science technology company, signed an agreement to jointly produce products for the biotechnology market, the university said Sunday. Professor Smadar Cohen and her research team have developed an alginate scaffold, which will be used to create a wide range of tissues, and - in partnership with Invitrogen - this will be put into production for the biotech/pharma market. "This is only the beginning of a pipeline of products to be developed using Ben-Gurion University's alginate scaffolds" said Dr Ora Horovitz, VP of Business Development at BG Negev Technologies.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS